Home › Funds › Boxer Capital Management, LLC › SRZN
Boxer Capital Management, LLC position in SRZN
SURROZEN INC · Health Care
Boxer Capital Management, LLC reported holding 1,360,683 shares of SRZN (SURROZEN INC) in its Q3 2026 13F filing — a position valued at US$43.8M, representing 3.81% of its reported portfolio and ranking #7 among its reported holdings. Boxer Capital Management, LLC has disclosed SRZN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Boxer Capital Management, LLC's SRZN position evolved
Boxer Capital Management, LLC first disclosed a stake in SRZN in Q4 2025 at 416,150 shares (US$9.4M). The position peaked in Q3 2026 at 1,360,683 shares, worth US$43.8M. Across 4 filings, Boxer Capital Management, LLC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,360,683 shares valued at US$43.8M — an increase of 255,000 shares quarter over quarter.. Notable position changes include a 84% increase in Q1 2026 (shares fell 11% over the following quarter), a 44% increase in Q2 2026 (shares rose 24% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 416.15K | $9.40M | New |
| Q1 2026 | 766.32K | $22.32M | Add |
| Q2 2026 | 1.11M | $26.96M | Add |
| Q3 2026 | 1.36M | $43.79M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About SRZN and 13F data
SRZN (SURROZEN INC) is a Health Care company. 59 other funds we track also report a position in SRZN — the largest reported positions include Column Group LLC (US$76.6M), Commodore Capital LP (US$28.5M), Venrock Adviser, LLC (US$20.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding SRZN
- Column Group LLC 2.95M sh · $76.59M · Q3 2026
- Commodore Capital LP 885.00K sh · $28.48M · Q3 2026
- Venrock Adviser, LLC 632.93K sh · $20.37M · Q3 2026
- Kynam Capital Management, LP 486.25K sh · $15.65M · Q3 2026
- Spruce Street Capital LP 432.04K sh · $13.90M · Q3 2026
- STEMPOINT CAPITAL LP 418.53K sh · $11.12M · Q3 2026
- Integral Health Asset Management, LLC 325.00K sh · $10.46M · Q3 2026
- Kalehua Capital Management LLC 286.09K sh · $9.21M · Q3 2026
- Vivo Capital, LLC 260.00K sh · $8.37M · Q3 2026
- ACUTA CAPITAL PARTNERS, LLC 152.54K sh · $4.91M · Q3 2026
- REGENTS OF THE UNIVERSITY OF CALIFORNIA 133.21K sh · $4.29M · Q3 2026
- Euclidean Capital LLC 87.70K sh · $2.82M · Q3 2026
More on Boxer Capital Management, LLC
FAQ
How long has Boxer Capital Management, LLC held SRZN?
Boxer Capital Management, LLC has disclosed SRZN holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Boxer Capital Management, LLC's current position in SRZN?
As of Q3 2026, Boxer Capital Management, LLC holds 1.36M shares of SRZN (SURROZEN INC), valued at $43.79M, representing 3.81% of its reported portfolio and ranking #7.
Has Boxer Capital Management, LLC been buying or selling SRZN?
In the latest 13F filing (Q3 2026), Boxer Capital Management, LLC increased its position in SRZN. The position peaked in Q3 2026 at 1.36M shares.
Which other funds hold SRZN?
Other major institutional holders of SRZN include Column Group LLC, Commodore Capital LP, Venrock Adviser, LLC, among 59 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.